Mayzent and Meningococcal conjugate vaccine
Determining the interaction of Mayzent and Meningococcal conjugate vaccine and the possibility of their joint administration.
In the database of official manuals used in the service creation an interaction registered by statistical results of studies was found, which can either lead to negative consequences for the patient health or strengthen a mutual positive effect. A doctor should be consulted to address the issue of joint drug administration.
Consumer:Consumer information for this interaction is not currently available.ADJUST DOSING INTERVAL: The administration of inactivated, killed, or otherwise noninfectious vaccines during siponimod therapy is generally safe but may be associated with a diminished or suboptimal immunologic response. Vaccination may be less effective during and for up to one month after discontinuation of siponimod therapy. MANAGEMENT: Immune response to vaccines may be reduced during and for up to one month after discontinuation of siponimod therapy. Treatment with siponimod should be paused 1 week prior to and for 4 weeks after vaccination. References "Product Information. Mayzent (siponimod)." Novartis Pharmaceuticals, East Hanover, NJ.
Professional:ADJUST DOSING INTERVAL: The administration of inactivated, killed, or otherwise noninfectious vaccines during siponimod therapy is generally safe but may be associated with a diminished or suboptimal immunologic response. Vaccination may be less effective during and for up to one month after discontinuation of siponimod therapy.
MANAGEMENT: Immune response to vaccines may be reduced during and for up to one month after discontinuation of siponimod therapy. Treatment with siponimod should be paused 1 week prior to and for 4 weeks after vaccination.
- "Product Information. Mayzent (siponimod)." Novartis Pharmaceuticals, East Hanover, NJ.
Generic Name: siponimod
Brand name: Mayzent, Mayzent Starter Pack
Synonyms: n.a.
Generic Name: meningococcal conjugate vaccine
Brand name: Menactra, Menveo
Synonyms: Meningococcal (Groups A / C / Y and W-135) Diphtheria Conjugate Vaccine
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Mayzent-Meningococcal group B vaccine
- Mayzent-Meningococcal Groups A, C, Y, and W-135 Vaccine
- Mayzent-Meningococcal Poly (Groups C & Y) & b Conj Vaccine
- Mayzent-Meningococcal polysaccharide vaccine, diphtheria conjugate Intramuscular
- Mayzent-Meningococcal vaccine and haemophilus b vaccine Intramuscular
- Mayzent-Meningococcal vaccine, diphtheria conjugate Intramuscular
- Meningococcal conjugate vaccine-Mayzent Starter Pack
- Meningococcal conjugate vaccine-Mb-Tab
- Meningococcal conjugate vaccine-MD-76 R
- Meningococcal conjugate vaccine-MD-Gastroview
- Meningococcal conjugate vaccine-Me NaPhos MB Hyo 1 Tablets
- Meningococcal conjugate vaccine-ME-500